- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Typhus.
Displaying page 1 of 1.
EudraCT Number: 2011-000381-35 | Sponsor Protocol Number: OVG 2011/02 | Start Date*: 2011-09-26 | ||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||
Full Title: Understanding typhoid disease after vaccination: a single centre, randomised, double-blind, placebo-controlled study to evaluate M01ZH09 in a healthy adult challenge model, using Ty21a vaccine as a... | ||||||||||||||||||
Medical condition: Active immunisation for the prevention of typhoid infection in healthy adults. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-001448-31 | Sponsor Protocol Number: H01_04E1TP | Start Date*: 2011-09-12 | |||||||||||
Sponsor Name:Novartis Vaccines Institute for Global Health (NVGH) | |||||||||||||
Full Title: A Phase 2, open-label, single-center, extension study to evaluate the booster response induced by Vi-CRM197 after priming with either Vi-CRM197 or Typherix administered in adult subjects in H01_04T... | |||||||||||||
Medical condition: Prophylaxis for Salmonella enterica serovar Typhi (S. Typhi) disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003653-26 | Sponsor Protocol Number: OVG2011/07 | Start Date*: 2011-12-08 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: A phase II, single-centre, randomised, single-blind, study to evaluate Vi-CRM197 against historical unvaccinated controls in a healthy adult challenge model, with a Vi-PS vaccine control arm. | |||||||||||||
Medical condition: Prophylaxis for Salmonella enterica serovar Typhi (S. Typhi) disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002978-36 | Sponsor Protocol Number: OVG2014/08 | Start Date*: 2015-01-26 | |||||||||||
Sponsor Name:The University of Oxford | |||||||||||||
Full Title: Vaccines Against Salmonella Typhi: a phase IIb, single centre, observer-blind, randomised controlled trial to assess the immunogenicity and protective efficacy of Vi conjugated (Vi-TCV) and unconju... | |||||||||||||
Medical condition: Salmonella enterica serovar Typhi infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000643-25 | Sponsor Protocol Number: 205520003 | Start Date*: 2011-04-19 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | ||||||||||||||||||
Full Title: The Qure study: Q-fever fatigue syndrome - response to treatment | ||||||||||||||||||
Medical condition: Q fever fatigue syndrome (QFS) is one of the most frequent sequelae of Q fever. QFS leads to substantial morbidity, a high socio-economic burden and an increased use of healthcare facilities. QFS: ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-018095-33 | Sponsor Protocol Number: 2009-40 | Start Date*: 2010-03-08 | |||||||||||
Sponsor Name:Institut Pasteur | |||||||||||||
Full Title: Evaluation d’outils de diagnostic sérologique discriminant une infection naturelle par le virus amaril d’une vaccination anti-amarile | |||||||||||||
Medical condition: réponse au vaccin anti-amaril chez des sujets adultes sains | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005566-33 | Sponsor Protocol Number: VYF03 | Start Date*: 2021-07-08 | |||||||||||
Sponsor Name:Sanofi Pasteur | |||||||||||||
Full Title: Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril® in Adults | |||||||||||||
Medical condition: Prevention of yellow fever | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) FI (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.